Use of cd25 antibodies in immunotherapy

Details Use of cd25 antibodies in immunotherapy Use of cd25 antibodies in immunotherapy

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2600709

A method for the treatment of proliferative disease or infectious disease, comprising administering to the patient an effective amount of a CD25 binding molecule.

L'invention concerne un procédé de traitement d'une maladie proliférative ou d'une maladie infectieuse qui consiste à administrer au patient une quantité efficace d'une molécule se liant à CD25.

Affiliated with

Also associated with

Rating

Use of cd25 antibodies in immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cd25 antibodies in immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cd25 antibodies in immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1905138